- €5.15bn
- €5.02bn
- €993.13m
- 51
- 47
- 68
- 57
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Interest Income | |||||
Interest Expense | |||||
Net Interest Income | 346 | 337 | 346 | 406 | 597 |
Loan Loss Provision | |||||
Net Interest Income After Loan Loss Provision | 334 | 314 | 321 | 365 | 513 |
Non Interest Income | |||||
Non Interest Expense | |||||
Net Income Before Taxes | 276 | 168 | 282 | 295 | 478 |
Provision for Income Taxes | |||||
Net Income After Taxes | 216 | 124 | 235 | 243 | 383 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 215 | 122 | 233 | 242 | 381 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 215 | 122 | 233 | 242 | 381 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 3.04 | 2.01 | 3.37 | 3.43 | 5.35 |
Dividends per Share |